查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1692400

胃滯留藥物輸送系統外包市場 - 全球產業規模、佔有率、趨勢、機會和預測，按劑型（片劑、液體、微球、膠囊等）區域和競爭細分，2020-2030 年

Gastroretentive Drug Delivery Systems Outsourcing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Dosage Form (Tablets, Liquid, Microspheres, Capsule, Others) Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球胃滯留藥物輸送系統外包市場價值為 13.7 億美元，預計到 2030 年將達到 18.9 億美元，預測期內複合年成長率為 5.51%。全球胃滯留藥物輸送系統外包市場是製藥和醫療保健產業內一個充滿活力且快速發展的產業。胃滯留給藥系統是指使藥物能夠在胃中停留較長時間的專門配方和技術，從而實現控制釋放和標靶治療效果。由於對提高藥物生物利用度、改善患者依從性並減少副作用的新型藥物輸送系統的需求不斷增加，該細分市場正在經歷顯著成長。

市場概況
預測期 2026-2030
2024 年市場規模 13.7 億美元
2030 年市場規模 18.9 億美元
2025-2030 年複合年成長率 5.51％
成長最快的領域 平板電腦
最大的市場 北美洲

胃腸道疾病等慢性疾病的發生率不斷上升，需要有效且患者友善的藥物傳遞解決方案。此外，人口老化和對先進製藥技術認知的不斷提高正在推動對胃滯留藥物輸送系統的需求。製藥業擴大將這些系統的開發和製造外包給專門的合約研究組織（CRO）和合約製造組織（CMO），以利用他們的專業知識並縮短產品上市時間。

該市場的特點是外包服務種類繁多，包括配方開發、臨床前和臨床測試以及胃滯留藥物輸送系統的商業規模生產。 CRO 和 CMO 在提供涵蓋研發、技術選擇、法規遵循和品質保證的端到端解決方案方面發揮關鍵作用。因此，製藥公司可以專注於藥物發現和臨床開發的核心競爭力，同時依靠外包合作夥伴來獲得胃滯留藥物輸送的專業知識。

此外，區域擴張、策略合作以及研發活動的投資也促進了市場的快速成長。隨著新型胃滯留藥物傳遞技術的發展，市場正在經歷創新的熱潮，包括漂浮系統、生物黏合系統和可擴展系統。

主要市場促進因素

胃腸道疾病盛行率上升

主要市場挑戰

智慧財產權問題

主要市場趨勢

靶向藥物傳輸需求不斷成長

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第4章：全球胃滯留藥物輸送系統外包市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按劑型（錠劑、液體、微球、膠囊、其他）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖
    • 按劑型
    • 按地區

第5章：亞太胃滯留藥物輸送系統外包市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按劑型
    • 按國家
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 澳洲
    • 日本
    • 韓國

第6章：歐洲胃滯留藥物輸送系統外包市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 德國
    • 西班牙
    • 義大利
    • 英國

第 7 章：北美胃滯留藥物輸送系統外包市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 墨西哥
    • 加拿大

第 8 章：南美洲胃滯留藥物輸送系統外包市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 阿根廷
    • 哥倫比亞

第 9 章：中東和非洲胃滯留藥物輸送系統外包市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 10 章：市場動態

  • 驅動程式
  • 挑戰

第 11 章：市場趨勢與發展

  • 最新動態
  • 產品發布
  • 合併與收購

第 12 章：全球胃滯留藥物輸送系統外包市場：SWOT 分析

第 13 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 14 章：競爭格局

  • Catalent, Inc
  • Lonza Group
  • Evonik Industries AG
  • Colorcon
  • Quotient Sciences
  • AptarGroup, Inc.
  • Aenova Holding GmbH
  • Evotec SE
  • Vectura Group Ltd
  • Ashland Inc.

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 20738

Global Gastroretentive Drug Delivery Systems Outsourcing Market was valued at USD 1.37 billion in 2024 and is expected to reach USD 1.89 billion by 2030 with a CAGR of 5.51% during the forecast period. The Global Gastroretentive Drug Delivery Systems Outsourcing Market is a dynamic and rapidly evolving sector within the pharmaceutical and healthcare industry. Gastroretentive drug delivery systems refer to specialized formulations and technologies that enable drugs to be retained in the stomach for an extended period, facilitating controlled release and targeted therapeutic effects. This market segment is witnessing significant growth due to the increasing demand for novel drug delivery systems that enhance drug bioavailability, improve patient compliance, and reduce side effects.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.37 Billion
Market Size 2030USD 1.89 Billion
CAGR 2025-20305.51%
Fastest Growing SegmentTablets
Largest MarketNorth America

the rising prevalence of chronic diseases, such as gastrointestinal disorders, which require effective and patient-friendly drug delivery solutions. Moreover, an aging population and increasing awareness of advanced pharmaceutical technologies are propelling the demand for gastroretentive drug delivery systems. The pharmaceutical industry is increasingly outsourcing the development and manufacturing of these systems to specialized contract research organizations (CROs) and contract manufacturing organizations (CMOs) to leverage their expertise and reduce time-to-market.

The market is characterized by a diverse range of outsourcing services, including formulation development, preclinical and clinical testing, and commercial-scale production of gastroretentive drug delivery systems. CROs and CMOs are playing a pivotal role in offering end-to-end solutions that encompass research and development, technology selection, regulatory compliance, and quality assurance. As a result, pharmaceutical companies can focus on their core competencies in drug discovery and clinical development, while relying on outsourcing partners for specialized expertise in gastroretentive drug delivery.

Furthermore, regional expansion, strategic collaborations, and investments in research and development activities are contributing to the market's rapid growth. The market is witnessing a surge in innovation, with the development of novel gastroretentive drug delivery technologies, including floating systems, bio adhesive systems, and expandable systems.

Key Market Drivers

Rising Prevalence of Gastrointestinal Disorders

The rising prevalence of gastrointestinal disorders is a pivotal driver behind the growth of the Global Gastroretentive Drug Delivery Systems Outsourcing Market. Gastrointestinal conditions, such as gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS), inflammatory bowel disease, and peptic ulcers, are becoming increasingly common worldwide. These disorders can significantly impact an individual's quality of life and managing them effectively often requires specialized pharmaceutical interventions.

According to World Gastroenterology Organisation, overall, 49% of females and 36.6% of males met criteria for at least one FGID - the most common disorders in all regions being functional constipation, functional dyspepsia, proctalgia fugax, functional diarrhea and IBS at prevalence rates of 11.7%, 7.2%, 5.9%, 4.7% and 4.1, respectively.

Gastroretentive drug delivery systems play a crucial role in addressing the challenges associated with treating gastrointestinal disorders. These innovative systems allow drugs to remain in the stomach for an extended period, ensuring localized treatment and controlled release of therapeutic agents. This approach not only enhances the bioavailability of drugs but also minimizes side effects and maximizes the effectiveness of treatment, providing much-needed relief to patients suffering from gastrointestinal ailments.

Key Market Challenges

Intellectual Property Concerns

In the competitive world of pharmaceuticals, companies invest heavily in research and development to create proprietary innovations, including gastroretentive drug delivery technologies. These innovations often form the core of their product portfolio and protecting them through IP rights is essential for maintaining a competitive edge. The fear of losing exclusive rights to these innovations can lead to hesitancy in sharing proprietary information with outsourcing partners, potentially hampering collaboration.

Collaborations between pharmaceutical companies and contract research organizations (CROs) or contract manufacturing organizations (CMOs) require a degree of information exchange. For the successful development and manufacturing of gastroretentive drug delivery systems, there's a need to share critical data, formulation knowledge, and technical expertise. However, striking the right balance between knowledge sharing and IP protection can be challenging. Pharmaceutical companies must carefully manage their IP while ensuring that their outsourcing partners have the necessary information to deliver high-quality products.

Key Market Trends

Increasing Demand for Targeted Drug Delivery

The Global Gastroretentive Drug Delivery Systems Outsourcing Market is experiencing a significant boost due to the increasing demand for targeted drug delivery solutions. This surge in demand is fueled by several factors and represents a key driving force shaping the future of the pharmaceutical outsourcing industry.

One of the most prominent factors driving the increasing demand for targeted drug delivery is the growing recognition of the limitations of traditional drug delivery methods. Conventional oral drug delivery often lacks specificity, with drugs being absorbed throughout the gastrointestinal tract. This can lead to reduced drug bioavailability and increased side effects, making it less than ideal for many therapeutic applications.

gastroretentive drug delivery systems offer a highly effective means of targeting specific regions within the gastrointestinal tract, particularly the stomach. These systems allow drugs to remain in the stomach for an extended duration, ensuring that they are delivered precisely where they are needed. This localized, site-specific approach not only enhances drug bioavailability but also minimizes unwanted side effects, improving the overall therapeutic outcomes for patients.

Key Market Players

  • Catalent, Inc
  • Lonza Group
  • Evonik Industries AG
  • Colorcon
  • Quotient Sciences
  • AptarGroup, Inc.
  • Aenova Holding GmbH
  • Evotec SE
  • Vectura Group Ltd
  • Ashland Inc.

Report Scope:

In this report, the Global Gastroretentive Drug Delivery Systems Outsourcing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Gastroretentive Drug Delivery Systems Outsourcing Market, By Dosage Form:

  • Tablets
  • Liquid
  • Microspheres
  • Capsule
  • Others

Gastroretentive Drug Delivery Systems Outsourcing Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Gastroretentive Drug Delivery Systems Outsourcing Market.

Available Customizations:

Global Gastroretentive Drug Delivery Systems Outsourcing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Gastroretentive Drug Delivery Systems Outsourcing Market Outlook

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share & Forecast
    • 4.2.1. By Dosage Form(Tablets, Liquid, Microspheres, Capsule, Others)
    • 4.2.2. By Region
    • 4.2.3. By Company (2024)
  • 4.3. Market Map
    • 4.3.1. By Dosage Form
    • 4.3.2. By Region

5. Asia Pacific Gastroretentive Drug Delivery Systems Outsourcing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Dosage Form
    • 5.2.2. By Country
  • 5.3. Asia Pacific: Country Analysis
    • 5.3.1. China Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
      • 5.3.1.1. Market Size & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share & Forecast
        • 5.3.1.2.1. By Dosage Form
    • 5.3.2. India Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
      • 5.3.2.1. Market Size & Forecast
        • 5.3.2.1.1. By Value
      • 5.3.2.2. Market Share & Forecast
        • 5.3.2.2.1. By Dosage Form
    • 5.3.3. Australia Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
      • 5.3.3.1. Market Size & Forecast
        • 5.3.3.1.1. By Value
      • 5.3.3.2. Market Share & Forecast
        • 5.3.3.2.1. By Dosage Form
    • 5.3.4. Japan Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
      • 5.3.4.1. Market Size & Forecast
        • 5.3.4.1.1. By Value
      • 5.3.4.2. Market Share & Forecast
        • 5.3.4.2.1. By Dosage Form
    • 5.3.5. South Korea Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
      • 5.3.5.1. Market Size & Forecast
        • 5.3.5.1.1. By Value
      • 5.3.5.2. Market Share & Forecast
        • 5.3.5.2.1. By Dosage Form

6. Europe Gastroretentive Drug Delivery Systems Outsourcing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Dosage Form
    • 6.2.2. By Country
  • 6.3. Europe: Country Analysis
    • 6.3.1. France Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Dosage Form
    • 6.3.2. Germany Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Dosage Form
    • 6.3.3. Spain Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Dosage Form
    • 6.3.4. Italy Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Dosage Form
    • 6.3.5. United Kingdom Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Dosage Form

7. North America Gastroretentive Drug Delivery Systems Outsourcing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Dosage Form
    • 7.2.2. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Dosage Form
    • 7.3.2. Mexico Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Dosage Form
    • 7.3.3. Canada Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Dosage Form

8. South America Gastroretentive Drug Delivery Systems Outsourcing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Dosage Form
    • 8.2.2. By Country
  • 8.3. South America: Country Analysis
    • 8.3.1. Brazil Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Dosage Form
    • 8.3.2. Argentina Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Dosage Form
    • 8.3.3. Colombia Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Dosage Form

9. Middle East and Africa Gastroretentive Drug Delivery Systems Outsourcing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Dosage Form
    • 9.2.2. By Country
  • 9.3. MEA: Country Analysis
    • 9.3.1. South Africa Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Dosage Form
    • 9.3.2. Saudi Arabia Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Dosage Form
    • 9.3.3. UAE Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Dosage Form

10. Market Dynamics

  • 10.1. Drivers
  • 10.2. Challenges

11. Market Trends & Developments

  • 11.1. Recent Developments
  • 11.2. Product Launches
  • 11.3. Mergers & Acquisitions

12. Global Gastroretentive Drug Delivery Systems Outsourcing Market: SWOT Analysis

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Product

14. Competitive Landscape

  • 14.1. Catalent, Inc
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Current Capacity Analysis
    • 14.1.5. Financials (In case of listed)
    • 14.1.6. Recent Developments
    • 14.1.7. SWOT Analysis
  • 14.2. Lonza Group
  • 14.3. Evonik Industries AG
  • 14.4. Colorcon
  • 14.5. Quotient Sciences
  • 14.6. AptarGroup, Inc.
  • 14.7. Aenova Holding GmbH
  • 14.8. Evotec SE
  • 14.9. Vectura Group Ltd
  • 14.10.Ashland Inc.

15. Strategic Recommendations

16. About Us & Disclaimer